Eli Lilly (LLY) said the response in India to its Mounjaro has been “positive,” adding it is focused on meeting demand for the drug in the country, Rishika Sadam of Reuters reports.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Eli Lilly (LLY) to Offer Higher Doses of Its Weight-Loss Drug on Website
- 3 Mega Cap Stocks with Potential to Beat the Market, 6/19/25
- Eli Lilly & Co: Strategic Growth Through VERV Acquisition and Pioneering Gene Editing
- Eli Lilly (LLY) Enters Gene-Editing Space with Verve Therapeutics Acquisition
- SanDisk initiated, Analog Devices upgraded: Wall Street’s top analyst calls
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue